OSR Health (OSRHW) Enterprise Value (2023 - 2026)
OSR Health (OSRHW) posted Enterprise Value of $21.7 million for Q1 2026, down 54.24% sequentially from $47.4 million in Q4 2025, and down 60.44% YoY from $54.9 million in Q1 2025.
OSR Health (OSRHW) Enterprise Value (2023 - 2026) Analysis & Trends
OSR Health has reported Enterprise Value for 4 years, with the latest figure at $21.7 million in Q1 2026.
- Quarterly Enterprise Value fell 60.44% year-over-year to $21.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.7 million (down 60.44% YoY) and the FY2025 annual result came in at $47.4 million, up 12080.55% from the prior year.
- Enterprise Value declined to $21.7 million in Q1 2026 per OSRHW's latest filing, from $47.4 million in the prior quarter.
- Over five years, Enterprise Value peaked at $54.9 million in Q1 2025 and troughed at -$70.6 million in Q1 2023.
- A 4-year average of $14.2 million and a median of -$3637.0 in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value plunged 2468.03% in 2024, then surged 1508823.26% in 2025.
- Over 4 years, Enterprise Value stood at -$15419.0 in 2023, then slumped by 2468.03% to -$395965.0 in 2024, then surged by 12080.55% to $47.4 million in 2025, then slumped by 54.24% to $21.7 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered $21.7 million, $47.4 million, and $50.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 2.12 Bn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | -1.16 Bn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 18.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.71 Mn |
| Dec 31, 2025 | 47.44 Mn |
| Sep 30, 2025 | 49.98 Mn |
| Jun 30, 2025 | 53.81 Mn |
| Mar 31, 2025 | 54.87 Mn |
| Dec 31, 2024 | -395,965.00 |
| Sep 30, 2024 | -12,236.00 |
| Mar 31, 2024 | -3,637.00 |
| Dec 31, 2023 | -15,419.00 |
| Sep 30, 2023 | -57,955.00 |
| Mar 31, 2023 | -70.63 Mn |